Literature DB >> 15359207

Intentional overdose of Large Animal Immobilon.

Joeri Sterken1, Joris Troubleyn, Frank Gasthuys, Viviane Maes, Mark Diltoer, Christian Verborgh.   

Abstract

We describe a case of voluntary self-injection with Large Animal Immobilon, a veterinary anaesthesia product containing etorphine, a very strong opioid, and acepromazine, a phenothiazine. This resulted in cardiorespiratory arrest and the need for sustained haemodynamic support after resuscitation. Large Animal Immobilon is used under specific conditions only, mainly in zoo and wildlife medicine. Primary toxicological analysis, although guided by the presumed toxin, could only detect a metabolite of acepromazine in the urine. Further analysis was able to show some traces of etorphine. A number of topics are treated, including the apparent potency of the etorphine and the selection of a suitable antidote, taking into account the different properties of the respective agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15359207     DOI: 10.1097/00063110-200410000-00013

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  4 in total

1.  Acute acepromazine overdose: clinical effects and toxicokinetic evaluation.

Authors:  D Adam Algren; Amber Ashworth
Journal:  J Med Toxicol       Date:  2015-03

Review 2.  Development of 5-Substituted N-Methylmorphinan-6-ones as Potent Opioid Analgesics with Improved Side-Effect Profile.

Authors:  Helmut Schmidhammer; Mariana Spetea
Journal:  Int J Med Chem       Date:  2012-06-17

3.  Acepromazine inhibits hERG potassium ion channels expressed in human embryonic kidney 293 cells.

Authors:  Young Shin Joo; Hong Joon Lee; Jin-Sung Choi; Ki-Wug Sung
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

Review 4.  Recent Chemical and Pharmacological Developments on 14-Oxygenated-N-methylmorphinan-6-ones.

Authors:  Mariana Spetea; Helmut Schmidhammer
Journal:  Molecules       Date:  2021-09-18       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.